✦ LIBER ✦

Shifting paradigms in prostate cancer; docetaxel plus low-dose prednisone – finally an effective chemotherapy

✍ Scribed by Ronald de Wit

Book ID: 116428445
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 104 KB
Volume: 41
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2004.12.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biweekly Administration of Low-Dose Doce

Biweekly Administration of Low-Dose Docetaxel in Hormone-Resistant Prostate Cancer: Pilot Study of an Effective Subtoxic Therapy

✍ Karavasilis, Vasilis; Briasoulis, Evangelos; Siarabi, Olga; Pavlidis, Nicholas 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 108 KB

705 ABIRATERONE ACETATE PLUS LOW-DOSE PR

705 ABIRATERONE ACETATE PLUS LOW-DOSE PREDNISONE HAS A FAVORABLE SAFETY PROFILE, IMPROVES SURVIVAL AND PRODUCES PSA AND RADIOGRAPHIC RESPONSES IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PROGRESSING AFTER DOCETAXEL-BASED CHEMOTHERAPY: RESULTS FROM COU-AA-301, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III STUDY

✍ Saad, Fred; de Bono, Johann S.; Haqq, Christopher M.; Logothetis, Christopher J. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 56 KB